Presentation on Rntcp Guidelines
-
Upload
varshasharma05 -
Category
Documents
-
view
224 -
download
0
Transcript of Presentation on Rntcp Guidelines
-
7/25/2019 Presentation on Rntcp Guidelines
1/35
PRESENTATION ONSAFE NURSING DRUG
ADMINISTRATIONBASED ON RNTCP
GUIDELINES RELATEDTO PEDAITRICTUBERCULOSIS
Presented by:
Ligy Mary Th!as
Ms" n#rsing
$a!ia %a!dard
-
7/25/2019 Presentation on Rntcp Guidelines
2/35
PEDIATRIC TUBERCULOSIS
The tuberculosis in childrenupto 14 years.The RNTCP Revised National
Tuberculosis Control Programme
-
7/25/2019 Presentation on Rntcp Guidelines
3/35
OBJECTIVESTo decrease mortality and morbidity by:Ensuring cureinimi!ing relapses
Preventing development o" drug resistanceTo decrease in"ections and brea# the chain o"
transmission o" in"ectionTo minimi!e the side e""ects due to anti$
tubercular drugs.
-
7/25/2019 Presentation on Rntcp Guidelines
4/35
PRINCIPLES
%ppropriate combination o" at least4 anti tubercular drugs to avoiddrug resistance
Prescription o" correct dosageTo be ta#en regularly and "or the
prescribed duration to prevent therelapse a"ter combination
-
7/25/2019 Presentation on Rntcp Guidelines
5/35
COMPONENTS
&omicilliary treatment%s e""ective as hospitali!ed treatmentNo e'tra ris# as a source o" in"ection
o" others
)hort course chemotherapyTreatment regimens "or *$+ months,iven either daily or intermittent
-
7/25/2019 Presentation on Rntcp Guidelines
6/35
CONTD.
-ntermittent regimen%s e""ective as daily regimen
&irect observation o" treatmentEnsures adherence
-
7/25/2019 Presentation on Rntcp Guidelines
7/35
CONTD.
The "irst to being given at the inpatientlevel in the hospitals.The short course chemotherapy is given in
to phases:
Intensi&e 'hase: here in /$0 drugs are giveninitially /$0 months2 hen the bacillary load ishigh and emergence o" drug resistance mutantscan be reduced.
Cntin#atin 'hase: this is ith "eer drugs "or alonger time o" 4$3 months and ensure eliminationo" bacteria hich are responsible "or relapses.
-
7/25/2019 Presentation on Rntcp Guidelines
8/35
CASE DEFINITIONS
Ne( Case: % patient ho has had no previous%TT or "or less than 4 ee#s.
Re)a'se: Patient declared curedcompletedtherapy in past and has evidence o" recurrence.
Treat!ent a*ter De*a#)t: % patient ho has
ta#en treatment "or at least 4 ee#s and comesa"ter interruption o" treatment "or / monthsand has active disease.
-
7/25/2019 Presentation on Rntcp Guidelines
9/35
CONTD.
P#)!nary TB re"ers to disease involving lungparenchyma.
E+tra P#)!nary TB re"ers to disease involving
sites other than lung parenchyma. -" bothpulmonary and e'tra pulmonary sites area""ected5 it ill be considered as Pulmonary "orregistration purposes. E'tra Pulmonary T6involving several sites should be de"ined bymost severe site.
-
7/25/2019 Presentation on Rntcp Guidelines
10/35
CONTD
Fai)#re t res'nd: % case o" pediatricT6 ho "ails to have bacteriologicalconversion to negative status or "ails to
respond clinically or deteriorates a"ter1/ ee#s o" compliant intensive phaseshall be deemed to have "ailed responseprovided alternative diagnoses reasons
"or non$response have been ruled out.
-
7/25/2019 Presentation on Rntcp Guidelines
11/35
-
7/25/2019 Presentation on Rntcp Guidelines
12/35
ANTI-TUBERCULAR DRUGS
The anti$tubercular drugs havethree main actions:
6actericidal activity)terili!ing activityThe ability to prevent resistance.
-
7/25/2019 Presentation on Rntcp Guidelines
13/35
-
7/25/2019 Presentation on Rntcp Guidelines
14/35
CONTD
The essential drugs used are:-sonia!id72sRi"ampicin R2Pyra!inamide 82)treptomycin )2Ethambutol E2
-sonia!id19mg#g2 "or * months inchildren "or chemoprophyla'is ho arein contact ith active tuberculosis eventhough e give 6C, vaccination
-
7/25/2019 Presentation on Rntcp Guidelines
15/35
CONTD
-sonia!id5 Ri"ampicin5 pyra!inamideand streptomycin are the mostpoer"ul bactericidal drugs.
Ri"ampicin is the most potentsterili!ing drug
Ethambutol is used in associationith more poer"ul drugs to preventthe development o" resistantTubercular bacilli
-
7/25/2019 Presentation on Rntcp Guidelines
16/35
DAILY V/S INTERMITTENT
REGIMEN
The intermittent therapy ill remain themainstay o" treating paediatric patients.
7oever5 children ith severe
disseminated disease5 Neuro$tuberculosisand seriously ill hospitalised childrenhaving high li#elihood o" vomiting andintolerance to oral drugs an initial dailysupervised therapy during their stay inthe hospital is needed.
-
7/25/2019 Presentation on Rntcp Guidelines
17/35
CONTD
%"ter discharge they ill be ta#enon thrice ee#ly &T regimenithsuitable modi"ication to thriceee#ly dosages2.
-
7/25/2019 Presentation on Rntcp Guidelines
18/35
DOSAGES
The "olloing are the daily doses mg per #g o"body eight per day2R$i"ampicin 19$1/ mg#g ma' *99 mgday25
-$sonia!id 19 mg#g ma' 099 mgday25P$yra!inamide P8%2 09$03mg#g ma' /999
mgday2E$thambutol /9$/3mg#g ma' 1399 mgday25)treptomycin 13 mg#g ma' 1gmday2.
-
7/25/2019 Presentation on Rntcp Guidelines
19/35
CATEGORIZATION
There ill be si' eight bands and threegeneric patient ise bo'es ill be used incombination to treat patients in the si' eight
bands.The neer eight bands*$+ #g;$1/ #g10$1* #g51
-
7/25/2019 Presentation on Rntcp Guidelines
20/35
CONTD
The categori!ation o"patients are the same as in
adults$-ntensi"ication phase$/monthsContinuation phase$ * months
-
7/25/2019 Presentation on Rntcp Guidelines
21/35
INSTRUCTIONS -mportant points to be remembered in drug
administration:
The nurse needs to be #noledgeable about thepharmaco#inetic o" drugs is based on ho a drugacts a"ter entering the body by absorption5distribution5 metabolism and e'cretion o" adrugs.
The nurse needs to be aare about the e""ectso" drugs on the body: therapeutic e""ects5 sidee""ects5 adverse e""ects5 to'ic e""ects5 allergicreaction.
-
7/25/2019 Presentation on Rntcp Guidelines
22/35
CONTD
The anti$tubercular drugs are used inmulti$combinations alays to avoidresistance.
These drugs need to ta#e regularly.The drugs have to be ta#en in accordance
ith the phase o" treatment hetherintensive or continuation
-
7/25/2019 Presentation on Rntcp Guidelines
23/35
CONTD
The anti$tubercular drugs havebactericidal e""ect even a"ter ithdraalas re"erred to as lag period needs to be
remembered.The antitubercular drugs have common
side e""ects hich the nurse has toin"orm the parents about li#e the
=aundice hen ta#ing isonia!id5 Ri"ampicinand pyra!inamide hile ethambutol hasimpaired vision as the side e""ect.
-
7/25/2019 Presentation on Rntcp Guidelines
24/35
CONTD
Chec# the physician>s order be"ore administeringthe drugs.
Read the medication label care"ully as manyproducts come in similar rappers5 colors andshapes.
?ollo the 19 rights o" drug administration hileadministering the drug.
-
7/25/2019 Presentation on Rntcp Guidelines
25/35
CONTD
The drugs can be crushed and administered tothe patients hen the child has di""iculty insalloing the drugs.
The child ho is able to sallo the drug5 thenurse has to place the drug under the tongue.
The nurse needs to chart the administration o"drug in the treatment card ith date5 time anddose.
onitor the a"ter a""ects o" the drugs andreport i" nay abnormal "indings to the physician.
The drug Ri"ampicin needs to be ta#en 1 hourbe"ore meal or / hours a"ter meals
-
7/25/2019 Presentation on Rntcp Guidelines
26/35
-
7/25/2019 Presentation on Rntcp Guidelines
27/35
-
7/25/2019 Presentation on Rntcp Guidelines
28/35
-
7/25/2019 Presentation on Rntcp Guidelines
29/35
-
7/25/2019 Presentation on Rntcp Guidelines
30/35
-
7/25/2019 Presentation on Rntcp Guidelines
31/35
-
7/25/2019 Presentation on Rntcp Guidelines
32/35
-
7/25/2019 Presentation on Rntcp Guidelines
33/35
-
7/25/2019 Presentation on Rntcp Guidelines
34/35
DRUG ADMINISTRATION
-t includes the observance o" the 19patients rights right patient5 right drug5right dose5 right route5 right time5 right
documentation5 right history5 right tore"use5 right evaluation5 right educationand in"ormation hich needs to bee'plained to the parents.
-
7/25/2019 Presentation on Rntcp Guidelines
35/35
NURSING RESPONSIBILITES
%dherenceNutrition
Counseling@i"estylePrecautions)ide e""ects